Cs. Lee et Nw. Gibson, DNA INTERSTRAND CROSS-LINKS INDUCED BY THE CYCLOPROPYLPYRROLOINDOLE ANTITUMOR AGENT BIZELESIN ARE REVERSIBLE UPON EXPOSURE TO ALKALI, Biochemistry, 32(35), 1993, pp. 9108-9114
Bizelesin, a cyclopropylpyrroloindole (CPI) antitumor agent, has been
shown to alkylate and cross-link DNA within A/T-rich tracts. Previous
studies have shown that covalent reaction of the CPI adozelesin with D
NA was reversible [Warpehoski, M. A., Harper, D. E., Mitchell, M. A.,
& Monroe, T. J. (1992) Biochemistry 31, 2502-2508]. That is, the monof
unctional adduct could be lost from DNA, thus restoring the fidelity o
f DNA. In this study, we demonstrate that covalent DNA adducts induced
by bizelesin at the adenine N3 position undergo two subsequent compet
ing reactions: one which causes DNA strand cleavage, via depurination,
and one which proceeds through loss of the DNA adduct (adduct reversa
l with restoration of DNA integrity). Our results were obtained by stu
dying the chemical stability of synthetic DNA oligonucleotides which c
ontained either a distinct DNA monofunctional adduct or DNA interstran
d cross-links. Quantification of adduct reversal was performed on the
basis that drug-modified DNA, upon exposure to heat followed by hot pi
peridine treatment, was resistant to strand cleavage at the site of al
kylation. The rate of adduct reversal was found to increase with incre
asing temperature and was found to be maximum at 70-80-degrees-C. The
rate of adduct reversal was also found to increase with increasing pH
and ionic strength. In contrast, the rate of depurination and subseque
nt DNA strand cleavage decreased as pH and ionic strength were increas
ed. Adduct reversal was favored in DNA containing interstrand cross-li
nks, whereas rapid depurination occurred preferentially within monofun
ctionally alkylated DNA.